1 Le laboratoire Digestivelab de l`Université McGill
Transcription
1 Le laboratoire Digestivelab de l`Université McGill
1 Le laboratoire Digestivelab de l’Université McGill est heureux de vous offrir un outil de dosage de la calprotectine fécale pour vos patients. La calprotectine fécale est maintenant établie comme étant un biomarqueur d’inflammation intestinale utile sur le plan clinique qui permet de distinguer les maladies inflammatoires de l’intestin du syndrome du colon irritable et de suivre l’évolution des maladies inflammatoires de l’intestin ainsi que la réponse au traitement. Grâce à une généreuse commandite d’un de nos partenaires, nous pouvons vous offrir cet outil diagnostique tout à fait gratuitement, incluant les frais d’expédition, pour un temps limité. Si vous êtes intéressé, veuillez communiquer avec Anne Duhaime (514934-8304 ; [email protected]) pour obtenir de plus amples renseignements. Avantages du dosage de la calprotectine fécale : Non invasif Plus précis que la mesure de la vitesse de sédimentation ou le dosage de la protéine C réactive Stable pendant 6 jours au réfrigérateur Résultats rapides Références : 1. Van Rheened PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010;341:c3369. 2. Sydora, M., Sydora, B. Fedorak, R. Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome. J Crohn’s and Colitis Online 2011 (sous presse) 3. Wassell J, Wallage M, Brewer E. Evaluation of the Quantum Blue(R) rapid test for faecal calprotectin. Ann Clin Biochem 2011 Sep 19. 4. Jensen MD, Kjeldsen J, Nathan T. Fecal calprotectin is equally sensitive in Crohn' s disease affecting the small bowel and colon. Scand J Gastroenterol 2011 Jun;46(6):694-700. Publication électronique : 1er avril 2011. 5. Dolci A, Panteghini M, Comparative study of a new quantitative rapid test with an established ELISA method for faecal calprotectin. Clin Chim Acta 2012 Jan 18;413-(1-2):350-1 6. Manz M, Burri E, Rothen C, Tchanguizi N, Niederberger C, Rossi L, Beglinger C, Lehmann FS. Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study. BMC Gastroenterol. 2012 Jan 10;12(1):5. [Prépublication électronique] 1 The McGill Digestivelab is pleased to offer fecal calprotectin testing for your patients. Fecal calprotectin has become established as a clinically useful biomarker for intestinal inflammation (IBD vs IBS) as well as to follow IBD activity and response to therapy. Thanks to a generous partnership between our lab and a corporate sponsor we can offer you this diagnostic test free of charge, including shipping, for a limited time. If you are interested please contact Anne Duhaime (514-934-8304; [email protected]) and she will provide you with more information. Benefits of fecal calprotectin testing: Non invasive More accurate than ESR or CRP Stable for 6 days when refrigerated Rapid results References: 1. Van Rheened PF, Van de Vijver E, Fidler V. Faecal calprotectin for screening of patients with suspected inflammatory bowel disease: diagnostic meta-analysis. BMJ 2010;341:c3369. 2. Sydora, M., Sydora, B. Fedorak, R. Validation of a point-of-care desk top device to quantitate fecal calprotectin and distinguish inflammatory bowel disease from irritable bowel syndrome. In press- J Crohn’s and Colitis. Online 2011 (In Press) 3. Wassell J, Wallage M, Brewer E. Evaluation of the Quantum Blue(R) rapid test for faecal calprotectin. Ann Clin Biochem 2011 Sep 19.; 4. Jensen MD, Kjeldsen J, Nathan T. Fecal calprotectin is equally sensitive in Crohn' s disease affecting the small bowel and colon. Scand J Gastroenterol. 2011 Jun;46(6):694-700. Epub 2011 Apr 1. 5. Dolci A, Panteghini M, Comparative study of a new quantitative rapid test with an established ELISA method for faecal calprotectin.Clin Chim Acta. 2012 Jan 18;413-(1-2):350-1 6. Manz M, Burri E, Rothen C, Tchanguizi N, Niederberger C, Rossi L, Beglinger C, Lehmann FS. Value of fecal calprotectin in the evaluation of patients with abdominal discomfort: an observational study. BMC Gastroenterol. 2012 Jan 10;12(1):5. [Epub ahead of print]